Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 155.33 | 110.99 | - | - |
Short Term Investments | 44.59 | 295.06 | 14.52 | 6.43 |
Cashand Short Term Investments | 199.92 | 406.64 | 15.74 | 15.73 |
Accounts Receivable- Trade Net | 15.53 | 32.71 | 27.74 | 17.58 |
Total Receivables Net | 15.75 | 43.93 | 51.85 | 38.48 |
Other Current Assets Total | 53.71 | 0.00 | 0.00 | 0.01 |
Total Current Assets | 269.38 | 454.96 | 71.15 | 59.80 |
Property/ Plant/ Equipment Total- Net | 108.61 | 107.28 | 95.12 | 95.11 |
Intangibles Net | 42.72 | 25.47 | 23.12 | 0.69 |
Long Term Investments | 25.49 | 27.41 | 23.18 | - |
Note Receivable- Long Term | 66.78 | 64.35 | 67.38 | 0.40 |
Other Long Term Assets Total | 2.06 | 150.66 | 0.13 | 73.69 |
Total Assets | 515.04 | 830.13 | 280.08 | 229.69 |
Accounts Payable | 142.29 | 148.25 | 72.19 | 99.06 |
Current Portof LT Debt/ Capital Leases | 50.49 | 3.06 | 76.78 | 39.67 |
Other Currentliabilities Total | 72.27 | 27.64 | 21.89 | 12.69 |
Total Current Liabilities | 265.05 | 178.95 | 171.43 | 233.35 |
Long Term Debt | 4.03 | - | 0.00 | 112.50 |
Capital Lease Obligations | 10.66 | 12.62 | 2.44 | 4.22 |
Total Long Term Debt | 14.69 | 12.62 | 2.44 | 116.72 |
Total Debt | 65.18 | 15.68 | 79.21 | 236.38 |
Other Liabilities Total | 109.55 | 125.79 | 74.99 | 47.87 |
Total Liabilities | 389.29 | 317.35 | 248.86 | 397.94 |
Common Stock Total | 32.45 | 32.45 | 27.19 | 26.21 |
Retained Earnings( Accumulated Deficit) | 93.30 | -1,557.84 | -1,336.61 | -1,134.91 |
Total Equity | 125.75 | 512.78 | 31.23 | -168.25 |
Total Liabilities Shareholders' Equity | 515.04 | 830.13 | 280.08 | 229.69 |
Total Common Shares Outstanding | 32.45 | 32.45 | 27.19 | 26.20 |
Tangible Book Valueper Share Common Eq | 2.56 | 15.02 | 0.30 | -6.45 |
Cash | - | 0.58 | 1.22 | 9.30 |
Total Inventory | - | 1.07 | 1.08 | 0.80 |
Prepaid Expenses | - | 3.33 | 2.48 | 4.79 |
Property/ Plant/ Equipment Total- Gross | - | 146.94 | 135.80 | 126.67 |
Accumulated Depreciation Total | - | -39.66 | -40.68 | -31.56 |
Accrued Expenses | - | 0.00 | 0.57 | 1.93 |
Notes Payable/ Short Term Debt | - | 0.00 | 0.00 | 80.00 |
Additional Paid- In Capital | - | 2,038.16 | 1,340.64 | 940.45 |
Sun Pharma Advanced Research Com Dividend Sun Pharma Advanced Research Com Bonus Sun Pharma Advanced Research Com News Sun Pharma Advanced Research Com AGM Sun Pharma Advanced Research Com Rights Sun Pharma Advanced Research Com Splits Sun Pharma Advanced Research Com Board Meetings Sun Pharma Advanced Research Com Key Metrics Sun Pharma Advanced Research Com Shareholdings Sun Pharma Advanced Research Com Profit Loss Sun Pharma Advanced Research Com Cashflow Sun Pharma Advanced Research Com Q1 Results Sun Pharma Advanced Research Com Q2 Results Sun Pharma Advanced Research Com Q3 Results Sun Pharma Advanced Research Com Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks